These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21839903)

  • 1. [Expenses of the Brazilian Ministry of Health for high-cost drugs: a demographic and clinical analysis].
    Brandão CM; Guerra AA; Cherchiglia ML; Andrade EI; Almeida AM; da Silva GD; de Queiroz OV; Faleiros DR; Acurcio Fde A
    Value Health; 2011; 14(5 Suppl 1):S71-7. PubMed ID: 21839903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
    Liu SZ; Romeis JC
    Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brazilian national health system: an unfulfilled promise?
    Ocké-Reis CO; Marmor TR
    Int J Health Plann Manage; 2010; 25(4):318-29. PubMed ID: 20066670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-pocket health expenses for Medicaid and other poor and near-poor persons in 1980.
    Howell E; Corder L; Dobson A
    Natl Med Care Util Expend Surv B; 1985 Aug; (4):1-52. PubMed ID: 10313450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit-incidence analysis of government spending on Ministry of Health outpatient services in Jordan.
    Halasa Y; Nassar H; Zaky H
    East Mediterr Health J; 2010 May; 16(5):467-73. PubMed ID: 20799544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of rheumatoid arthritis in the Brazilian Unified National Health System: expenditures on infliximab compared to synthetic disease-modifying anti-rheumatic drugs, 2003-2006].
    Costa Jde O; Almeida AM; Guerra AA; Cherchiglia ML; Andrade EI; Acurcio Fde A
    Cad Saude Publica; 2014 Feb; 30(2):283-95. PubMed ID: 24627057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
    Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
    Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pricing-out effect from possible user-fee policies under Taiwan's National Health Insurance.
    Chen WY; Liang YW; Lin YH
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):453-64. PubMed ID: 20715921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental Health Policy in Brazil: federal expenditure evolution between 2001 and 2009.
    Gonçalves RW; Vieira FS; Delgado PG
    Rev Saude Publica; 2012 Feb; 46(1):51-8. PubMed ID: 22183515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.
    Almeida AM; da Silva AL; Cherchiglia ML; Andrade EI; de Oliveira GL; Acurcio Fde A
    Value Health; 2011; 14(5 Suppl 1):S24-8. PubMed ID: 21839893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of demographic chance on pharmaceutical expenses in private health insurance--a scenario-based analysis].
    Böcking W; Tidelski O; Skuras B; Bäumler A; Kitzmann F
    Dtsch Med Wochenschr; 2012 Aug; 137(31-32):1595-600. PubMed ID: 22872541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-dependent prioritisation of health-care spending--perspectives for the German health-care system].
    Esslinger AS; Franke S; Heppner HJ
    Gesundheitswesen; 2007 Jan; 69(1):11-7. PubMed ID: 17347927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Public health financing by the Paraná State Government, Brazil, 1991-2006].
    Carvalho Md; Paulus Júnior A; Cordoni L
    Cad Saude Publica; 2008 Nov; 24(11):2532-40. PubMed ID: 19009133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.